Ethylbromazolam is a designer drug of the benzodiazepine class, a derivative of bromazolam and has similar effects. This drug was first discovered in 2025 and is currently poorly understood, with little data available on its pharmacological properties.
Chemistry
Ethylbromazolam is a derivative of bromazolam and has a related chemical structure, with a slight difference, the methyl group is replaced by an ethyl group in the triazole ring.
Pharmacology
Ethylbromazolam is a designer substance and its toxicological and pharmacological properties have not been fully studied, according to studies in mice it acts as a sedative and hypnotic drug.
Legal status
It’s not clear, it’s a research substance. An analog of bromazolam.
Product Name: Ethylbromazolam
Other Name(s):
IUPAC Name: 8-bromo-1-ethyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
CAS:
Molar Mass: 367.2 g/mol
Molecular Formula: C18H15BrN4
InChi Code:
InChIKey: DKTGBMWWLATMHK-UHFFFAOYSA-N
Canonical SMILES: CCC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4
Formulation: A crystalline solid

Create a preliminary purchase request. Check stock availability. Communication with support:
Gidazepam
Deschloroetizolam
Pynazolam
Flubrotizolam
Ethylbromazolam
Fluetizolam
Fluoprazolam
Clobromazolam 





